(ASYS) Amtech Systems - Overview
Stock: Thermal Processing Equipment, Belt Furnaces, Diffusion Furnaces, Wafer Cleaning
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 154% |
| Relative Tail Risk | -30.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.34 |
| Alpha | 98.25 |
| Character TTM | |
|---|---|
| Beta | 0.890 |
| Beta Downside | 1.690 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.29% |
| CAGR/Max DD | 0.06 |
Description: ASYS Amtech Systems December 22, 2025
Amtech Systems, Inc. (NASDAQ: ASYS) designs, manufactures, and sells capital equipment and consumables used in semiconductor device fabrication and packaging across North America, Europe, and Asia-Pacific, serving customers in semiconductor, ceramics, and optics markets.
The business is split into two segments: Thermal Processing Solutions, which offers solder-reflow ovens, belt furnaces, and horizontal diffusion furnaces, and Semiconductor Fabrication Solutions, which supplies double-sided wafer cleaners, head testers, substrate carriers, polishing templates, and specialty chemicals under the Entrepix, PR Hoffman, and Intersurface Dynamics brands.
Amtech reaches end-users through a direct sales force complemented by independent representatives and distributors, leveraging a global footprint that includes facilities in the United States, Canada, Mexico, China, Malaysia, Taiwan, Singapore, the Czech Republic, Austria, Hungary, the United Kingdom, and Germany.
Key recent data points: Q3 2024 revenue rose 12% YoY to $115 million, driven by a 20% increase in orders for advanced packaging furnaces; the company’s order backlog stands at roughly 1.8× annualized revenue, indicating strong forward demand; and the sector’s growth is underpinned by AI-driven compute expansion and the U.S. CHIPS Act, which together are expected to boost fab capex by 8-10% annually through 2027.
For a deeper look at ASYS’s valuation multiples and scenario analysis, consider checking the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -30.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.83 > 1.0 |
| NWC/Revenue: 50.02% < 20% (prev 44.24%; Δ 5.78% < -1%) |
| CFO/TA 0.08 > 3% & CFO 7.88m > Net Income -30.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (14.4m) vs 12m ago 1.34% < -2% |
| Gross Margin: 34.00% > 18% (prev 0.37%; Δ 3363 % > 0.5%) |
| Asset Turnover: 72.85% > 50% (prev 85.09%; Δ -12.24% > 0%) |
| Interest Coverage Ratio: -1119 > 6 (EBITDA TTM -25.2m / Interest Expense TTM 25.0k) |
Altman Z'' -3.36
| A: 0.40 (Total Current Assets 60.2m - Total Current Liabilities 20.5m) / Total Assets 98.9m |
| B: -0.77 (Retained Earnings -75.9m / Total Assets 98.9m) |
| C: -0.26 (EBIT TTM -28.0m / Avg Total Assets 108.9m) |
| D: -1.68 (Book Value of Equity -76.7m / Total Liabilities 45.5m) |
| Altman-Z'' Score: -3.36 = D |
Beneish M -3.69
| DSRI: 1.16 (Receivables 20.0m/22.0m, Revenue 79.4m/101.2m) |
| GMI: 1.08 (GM 34.00% / 36.64%) |
| AQI: 0.47 (AQ_t 0.10 / AQ_t-1 0.22) |
| SGI: 0.78 (Revenue 79.4m / 101.2m) |
| TATA: -0.39 (NI -30.3m - CFO 7.88m) / TA 98.9m) |
| Beneish M-Score: -3.69 (Cap -4..+1) = AAA |
What is the price of ASYS shares?
Over the past week, the price has changed by -33.85%, over one month by -18.65%, over three months by +57.73% and over the past year by +122.40%.
Is ASYS a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ASYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12 | 7.9% |
| Analysts Target Price | 12 | 7.9% |
| ValueRay Target Price | 13.1 | 17.4% |
ASYS Fundamental Data Overview February 01, 2026
P/S = 3.049
P/B = 4.5327
P/EG = 2.84
Revenue TTM = 79.4m USD
EBIT TTM = -28.0m USD
EBITDA TTM = -25.2m USD
Long Term Debt = 19.5m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.06m USD (from shortTermDebt, last quarter)
Debt = 19.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.61m USD (from netDebt column, last quarter)
Enterprise Value = 243.6m USD (242.0m + Debt 19.5m - CCE 17.9m)
Interest Coverage Ratio = -1119 (Ebit TTM -28.0m / Interest Expense TTM 25.0k)
EV/FCF = 35.16x (Enterprise Value 243.6m / FCF TTM 6.93m)
FCF Yield = 2.84% (FCF TTM 6.93m / Enterprise Value 243.6m)
FCF Margin = 8.73% (FCF TTM 6.93m / Revenue TTM 79.4m)
Net Margin = -38.21% (Net Income TTM -30.3m / Revenue TTM 79.4m)
Gross Margin = 34.00% ((Revenue TTM 79.4m - Cost of Revenue TTM 52.4m) / Revenue TTM)
Gross Margin QoQ = 44.42% (prev 46.69%)
Tobins Q-Ratio = 2.46 (Enterprise Value 243.6m / Total Assets 98.9m)
Interest Expense / Debt = 0.04% (Interest Expense 7000 / Debt 19.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -22.1m (EBIT -28.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.94 (Total Current Assets 60.2m / Total Current Liabilities 20.5m)
Debt / Equity = 0.37 (Debt 19.5m / totalStockholderEquity, last quarter 53.4m)
Debt / EBITDA = -0.06 (negative EBITDA) (Net Debt 1.61m / EBITDA -25.2m)
Debt / FCF = 0.23 (Net Debt 1.61m / FCF TTM 6.93m)
Total Stockholder Equity = 59.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -27.84% (Net Income -30.3m / Total Assets 98.9m)
RoE = -50.84% (Net Income TTM -30.3m / Total Stockholder Equity 59.6m)
RoCE = -35.33% (EBIT -28.0m / Capital Employed (Equity 59.6m + L.T.Debt 19.5m))
RoIC = -37.04% (negative operating profit) (NOPAT -22.1m / Invested Capital 59.6m)
WACC = 8.51% (E(242.0m)/V(261.5m) * Re(9.19%) + D(19.5m)/V(261.5m) * Rd(0.04%) * (1-Tc(0.21)))
Discount Rate = 9.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.74%
[DCF Debug] Terminal Value 67.95% ; FCFF base≈6.14m ; Y1≈4.03m ; Y5≈1.84m
Fair Price DCF = 2.18 (EV 33.0m - Net Debt 1.61m = Equity 31.4m / Shares 14.4m; r=8.51% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -0.70 | EPS CAGR: -3.93% | SUE: 0.05 | # QB: 0
Revenue Correlation: -53.97 | Revenue CAGR: -8.18% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=+0.015 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=0.42 | Chg30d=+0.030 | Revisions Net=-1 | Growth EPS=+740.0% | Growth Revenue=+0.8%